Enclomiphene citrate stimulates serum testosterone in men with low testosterone within 14 days

Journal of Men's Health

Volumn 11, Issue 4, 2014, Pages 196-205

  Wiehle, Ronald D ^a   Fontenot, Gregory K ^a   Willett, Michael S ^b   Garcia, Wilfredo D ^b   Podolski, Joseph S ^a  

^a Repros Therapeutics Inc   (United States)

^b NicheUSA LLC   (United States)

Author keywords

Clomid; Clomiphene citrate; Enclomiphene citrate; Secondary hypogonadism; Testosterone replacement therapy

Indexed keywords

ANDROSTANOLONE; ENCLOMIFENE CITRATE; TESTOSTERONE;

ADULT; AGED; ANDROGEN THERAPY; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ABSORPTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG SAFETY; ELIMINATION HALF-LIFE; HUMAN; HYPOGONADISM; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PHARMACODYNAMICS; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; STEADY STATE; TESTOSTERONE BLOOD LEVEL; TOPICAL TREATMENT;

EID: 84914821529     PISSN: 18756867     EISSN: 18756859     Source Type: Journal    
DOI: 10.1089/jomh.2014.0006     Document Type: Article

References (37)

1. Kaufman JM, Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 2005;26:833-876.
2. Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in adult men with androgen deficiency syndromes: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2010;95:2536-2559.
3. Buvat J, Maggi M, Guay A, Torres LO. Testosterone deficiency in men: Systematic review and standard operating procedures for diagnosis and treatment. J Sex Med 2013;10: 245-284.
4. Catt KJ, DuFau ML. Gonadotropic hormones: biosynthesis, secretion, receptors, and actions. In: Yen SSC, Jaffe RB, eds. Reproductive endocrinology: Physiology, pathophysiology, and clinical management, 3rd ed. Philadelphia: W.B. Saunders Company 1991:105-155.
5. Harman SM, Metter EJ, Tobin JD, Pearson J, BlackmanMR. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 2001;86:724-731.
6. Mohr BA, Guay AT, O'Donnell AB, McKinlay JB. Normal, bound and nonbound testosterone levels in normally ageing men: Results from the Massachusetts Male Ageing Study. Clin Endocrinol (Oxf) 2005;62:64-73.
7. Carruthers M. Time for international action on treating testosterone deficiency Syndrome. Aging Male 2009;12:21-28.
8. Calof OM, Singh AB, Lee ML, et al. Adverse events associated with testosterone replacement in middle-aged and older men: A meta-analysis of randomized, placebo-controlled trials. J Gerontol A Biol Sci Med Sci 2005;60:1451-1457.
9. Swerdloff RS, Wang C. Transdermal androgens: pharmacology and applicability to hypogonadal elderly men. J Endocrinol Invest 2005;28:112-116.
10. Basaria S, Coviello AD, Travison TG, et al. Adverse events associated with testosterone administration. N Engl J Med 2010;8:109-122.
11. Pöllänen P, Nikkanen V, Huhtaniemi I. Combination of subcutaneous levonorgestrel implants and transdermal dihydrotestosterone gel for male hormonal contraception. Int J Androl 2001;24:369-380.
12. Abadilla KA, Dobs AS. Topical testosterone supplementation for the treatment of male hypogonadism. Drugs 2012; 72:1591-603.
13. Büchter D, von Eckardstein S, von Eckardstein A, et al. Clinical trial of transdermal testosterone and oral levonorgestrel for male contraception. J Clin Endocrinol Metab. 1999;84:1244-1249.
14. Ilani N, Roth MY, Amory JK, et al. A new combination of testosterone and nestorone transdermal gels for male hormonal contraception. J Clin Endocrinol Metab 2012;97 3476-3486.
15. Mahabadi V, Amory JK, Swerdloff RS, et al. Combined Transdermal testosterone gel and the progestin nestorone suppresses serum gonadotropins in men. J Clin Endocrinol Metab 2009;94:2313-2320.
16. Clark J, Guthrie SC. Agonistic and antagonistic effects of clomiphene citrate and its isomers. Biol Reprol 1981;25: 667-672.
17. Fitzpatrick SL, Berrodin TJ, Jenkins SF, Sindoni DM, Deecher DC, Frail DE. Effect of estrogen agonists and antagonists on induction of progesterone receptor in a rat hypothalamic cell line. Endocrinology 1999;140:3928-3937.
18. Burghardt RC, Gaddy-Kurten D, Burghardt RL, Kurten RC, Mitchell PA. Gap junction modulation in rat uterus. III. Structure-activity relationships of estrogen receptor-binding ligands on myometrial and serosal cells. Biol Reprod 1987; 36:741-751.
19. Young RL, Goldzieher JW, Chakraborty PK, Panko WB, Bridges CN. Qualitative differences in estrogenic/antiestrogenic effects of clomiphene and Zuclomiphene. Int J Fertil 1991;36:291-295.
20. Guay AT, Bansal S, Heatley GJ. Effect of raising endogenous testosterone levels in impotent men with secondary hypogonadism: Double blind placebo-controlled trial with clomiphene citrate. J Clin Endocrinol Meta 1995;80:3546-3552.
21. Guay AT, Jacobson J, Perez JB, Hodge MB, Velasquez E. Clomiphene increases free testosterone levels in men with both secondary hypogonadism and erectile dysfunction: Who does and does not benefit? Int J Impot Res 2003;15:156-165.
22. Hussein A, Ozgok Y, Ross L, Niederberger C. Clomiphene administration for cases of nonobstructive azoospermia: a multicenter study. J Androl 2005;26:787-791, discussion 792-793.
23. Shabsigh A, Kang Y, Shabsigh R, Gonzalez M, et al. Clomiphene citrate effects on testosterone/estrogen ratio in male hypogonadism. J Sex Med 2005;2:716-721.
24. Tan RS, Vasudevan D. Use of clomiphene citrate to reverse premature andropause secondary to steroid abuse. Fertil Steril 2003;79:203-205.
25. Kaminetsky J, Werner M, Fontenot G, Wiehle RD. Oral enclomiphene citrate stimulates the endogenous production of testosterone and sperm counts in men with low testosterone: comparison with testosterone gel. J Sex Med 2013;10: 1628-1635.
26. Wiehle R, Cunningham GR, Pitteloud N, Wike J, et al. Testosterone restoration by enclomiphene citrate in men with secondary hypogonadism: Pharmacodynamics and pharmacokinetics. BJU Int 2013;112:1188-1200.
27. Morley JE, Charlton E, Patrick P, et al. Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism 2000;49:1239-1242.
28. Kacker R, Hornstein A, Morgentaler A. Free testosterone by direct and calculated measurement versus equilibrium dialysis in a clinical population. Aging Male 2013;16: 164-168.
29. Swerdloff RS, Wang C. The testis and male sexual function. In: Goldman L, Schafer AI, eds. Cecil medicine, 24th ed. Philadelphia: Saunders Elsevier; 2011:chap 242.
30. Veldhuis JD, Roemmich JN, Richmond EJ, Bowers CY. Somatotropic and gonadotropic axes linkages in infancy, childhood, and the puberty-adult transition. Endocr Rev 2006;27:101-140.
31. Pincus SM, Veldhuis JD, Mulligan T, Iranmanesh A, Evans WS. Effects of age on the irregularity of LH and FSH serum concentrations in women and men. Am J Physio 1997:273: E989-995.
32. Carlstrom K, Fredricsson B. Effect of clomiphene citrate on testicular steroid metabolism in man. Int J Androl 1980;3: 417-428.
33. Swerdloff RS, Wang C, Cunningham G. Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men. J Clin Endocrinol Metab 2005;85:4500-4510.
34. Tenover JS, Dahl KD, Hsueh AJ, Lim P, Matsumoto AM, Bremner WJ. Serum bioactive and immunoreactive folliclestimulating hormone levels and the response to clomiphene in healthy young and elderly men. J Clin Endocrinol Metab 1987;64:1103-1108.
35. Hoffmann R. Enzymology of the hair follicle. Eur J Dermatol 2001;11:296-300.
36. Russell DW, Wilson JD. Steroid 5 alpha-reductase: Two genes/two enzymes. Annu Rev Biochem 1994;63:25-61.
37. Resko JA, Eik-Nes KB. Diurnal testosterone levels in peripheral plasma of human male subjects. J Clin Endocrinol Metab 1966;26:573-576.